- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Aliquots are pre-aliquoted, commercially available drugs from the EU. Our aliquots thus contain therapeutic molecules manufactured by the original drug license holder and repackaged by Evidentic.
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
CD80 , CD86 |
Fusion protein |
Orencia® |
25 mg/mL |
yes |
5 mg |
-80°C |
02/2023 |
194,40 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Amgevita® |
50 mg/mL |
– |
2 mg |
-80°C |
12/2021 |
265,50 € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
– |
4 mg |
-80°C |
11/2023 |
438,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Hulio® |
50 mg/mL |
– |
2 mg |
-80°C |
02/2023 |
265,50 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Hukyndra® |
100 mg/mL |
– |
2 mg |
-80°C |
10/2023 |
344,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Yuflyma® |
100 mg/mL |
– |
4 mg |
-80°C |
02/2024 |
344,00 € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
09/2018 |
394,20 € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
12/2018 |
394,20 € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
03/2019 |
394,20 € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
03/2019 |
394,20 € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
07/2019 |
394,20 € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
12/2019 |
394,20 € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
03/2020 |
394,20 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Idacio® |
50 mg/mL |
– |
2 mg |
-80°C |
10/2023 |
345,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Imraldi® |
50 mg/mL |
– |
2 mg |
-80 °C |
10/2023 |
295,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Hyrimoz® |
50 mg/mL |
– |
2 mg |
-80°C |
06/2024 |
295,00 € |
||
PlGF , VEGF-A , VEGF-B |
Fusion protein |
Zaltrap® |
25 mg/mL |
– |
2 mg |
tba |
tba |
197,00 € |
||
PIGF , VEGF-A |
Fusion protein |
Eylea® |
40 mg/mL |
– |
0,8 mg |
-80°C |
11/2021 |
548,10 € |
||
Clotting Factor IX |
Fusion protein |
Idelvion® |
200 IU/mL |
– |
25 IU |
-80°C |
01/2023 |
438,30 € |
||
IL-2RB |
Recombinant protein |
Proleukin® |
1,1 mg/mL |
– |
0,088 mg |
-80°C |
03/2024 |
495,00 € |
||
IL-2RB |
Recombinant protein |
Proleukin® |
1,1 mg/mL |
– |
0,044 mg |
-80°C |
07/2024 |
337,00 € |
||
CD52 |
Monoclonal Antibody |
Lemtrada® |
10 mg/mL |
– |
0,5 mg |
-80°C |
08/2022 |
1.815,30 € |
||
Plasminogen activator (rt-PA) |
Glycoprotein |
Actilyse® |
1 mg/mL |
– |
0.4 mg |
-80°C |
02/2023 |
230,40 € |
||
EGFR , MET |
Bispecific Antibody |
Rybrevant® |
50 mg/ml |
– |
7 mg |
-80°C |
11/2023 |
365,00 € |
||
PD-L1 |
Monoclonal Antibody-Fc engineered |
Tecentriq® |
60 mg/mL |
yes |
12 mg |
-80°C |
03/2022 |
262,80 € |
||
PD-L1 |
Monoclonal Antibody-Fc engineered |
Tecentriq® |
60 mg/mL |
yes |
12 mg |
-80°C |
05/2023 |
263,00 € |
||
PD-L1 |
Monoclonal Antibody |
Bavencio® |
20 mg/mL |
– |
2 mg |
-80°C |
01/2021 |
125,10 € |
||
BCMA |
Antibody-drug conjugate (ADC) |
Blenrep® |
50 mg/mL |
– |
2 mg |
tba |
tba |
649,00 € |
||
CD80 , CD86 |
Fusion protein |
Nulojix® |
25 mg/mL |
– |
5 mg |
-80°C |
01/2025 |
214,00 € |
||
VEGF |
Monoclonal Antibody |
Zirabev® |
25 mg/mL |
– |
2 mg |
tba |
tba |
200,00 € |
Evidentic GmbH
Martin-Buber-Str. 10
14163 Berlin